SELECTIVE INDUCTION OF PROTECTION AGAINST INFLUENZA-VIRUS INFECTION IN MICE BY A LIPID-PEPTIDE CONJUGATE DELIVERED IN LIPOSOMES

被引:30
作者
FRIEDE, M
MULLER, S
BRIAND, JP
PLAUE, S
FERNANDES, I
FRISCH, B
SCHUBER, F
VANREGENMORTEL, MHV
机构
[1] IBMC, CNRS, UPR IMMUNOCHIM PEPTIDES & VIRUS 9021, F-67000 STRASBOURG, FRANCE
[2] UNIV STRASBOURG 1, FAC PHARM, CHIM BIOORGAN LAB, CNRS, URA 1386, STRASBOURG, FRANCE
[3] NEOSYST, STRASBOURG, FRANCE
关键词
INFLUENZA VIRUS; LIPID-PEPTIDE CONJUGATE; LIPOSOMES;
D O I
10.1016/0264-410X(94)90287-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have previously reported (Muller ct al. Vaccine 1990, 8, 308) that two cyclic peptide analogues called D loop and K loop, corresponding to residues 139-147 in site A of the haemagglutinin (HA) of influenza A virus (strain X31), were both able to provide protective immunity to infected OF1 mice when administered in the form of peptide-ovalbumin conjugates. The predicted conformation of the D loop is nearly identical to that of the native loop known from the X-ray structure of HA, while the predicted conformation of the K loop differs significantly from the native one. In this study, the two peptides were conjugated to small unilamellar liposomes, thus creating a chemically defined immunogen, and OF1 mice were immunized with these liposomes containing monophosphoryl lipid A as adjuvant. Compared with protein carrier systems, the liposomal preparations are completely synthetic and avoid the use of Freund's adjuvant. By using liposomes associated with the D loop, we were able to achieve 70% protection of the mice against intranasal challenge with the influenza virus while no protection was obtained with the liposome-associated K loop. The difference in effect between the two liposome and ovalbumin carrier systems may result from the induction of different structures in the peptides when coupled to lipid anchors than when coupled to proteins.
引用
收藏
页码:791 / 797
页数:7
相关论文
共 49 条
  • [1] LIPOSOMES AS IMMUNOLOGICAL ADJUVANTS
    ALLISON, AC
    GREGORIADIS, G
    [J]. NATURE, 1974, 252 (5480) : 252 - 252
  • [2] ALVING C, 1989, J IMMUNOL METHODS, V140, P1
  • [3] EFFECTIVENESS OF LIPOSOMES AS POTENTIAL CARRIERS OF VACCINES - APPLICATIONS TO CHOLERA-TOXIN AND HUMAN MALARIA SPOROZOITE ANTIGEN
    ALVING, CR
    RICHARDS, RL
    MOSS, J
    ALVING, LI
    CLEMENTS, JD
    SHIBA, T
    KOTANI, S
    WIRTZ, RA
    HOCKMEYER, WT
    [J]. VACCINE, 1986, 4 (03) : 166 - 172
  • [4] LIPOSOMES CONTAINING LIPID-A - A POTENT NONTOXIC ADJUVANT FOR A HUMAN MALARIA SPOROZOITE VACCINE
    ALVING, CR
    RICHARDS, RL
    [J]. IMMUNOLOGY LETTERS, 1990, 25 (1-3) : 275 - 280
  • [5] EFFICACY OF INFLUENZA HEMAGGLUTININ AND NUCLEOPROTEIN AS PROTECTIVE ANTIGENS AGAINST INFLUENZA-VIRUS INFECTION IN MICE
    ANDREW, ME
    COUPAR, BEH
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1988, 28 (01) : 81 - 85
  • [6] STRUCTURAL BASIS OF ANTIGENIC SPECIFICITY AND DESIGN OF NEW VACCINES
    ARNON, R
    VANREGENMORTEL, MHV
    [J]. FASEB JOURNAL, 1992, 6 (14) : 3265 - 3274
  • [7] SYNTHETIC PEPTIDES AS THE BASIS FOR VACCINE DESIGN
    ARNON, R
    [J]. MOLECULAR IMMUNOLOGY, 1991, 28 (03) : 209 - 215
  • [8] ARNON R, 1987, SYNTHETIC VACCINES, V1
  • [9] BRAND CM, 1972, NATURE-NEW BIOL, V238, P841
  • [10] APPLICATION AND LIMITATIONS OF THE MULTIPLE ANTIGEN PEPTIDE (MAP) SYSTEM IN THE PRODUCTION AND EVALUATION OF ANTIPEPTIDE AND ANTIPROTEIN ANTIBODIES
    BRIAND, JP
    BARIN, C
    VANREGENMORTEL, MHV
    MULLER, S
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1992, 156 (02) : 255 - 265